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a b s t r a c t
Skin cancer is extremely common, and melanoma causes about 80% of skin cancer deaths. In fact, mela-
noma kills over 50 thousand people around the world each year, and these numbers are rising. Clearly,
standard treatments are not effectively treatingmelanoma, and alternative therapies are needed to address
this problem. Hibiscus tea has been noted to have medicinal properties, including anticancer effects. Ex-
tracts from Hibiscus have been shown to inhibit the growth of a variety of cancer cells. In particular, recent
studies found that polyphenols extracted fromHibiscus sabdariffa byorganic solvents can inhibitmelanoma
cell growth. However, effects of aqueous extracts from Hibiscus rosa-sinesis ﬂowers, which are commonly
used tomake traditional medicinal beverages, have not been examined onmelanoma cells. Here, we report
that aqueousH. rosa-sinesisﬂower extract contains compounds that inhibitmelanoma cell growth in a dose
dependent manner at concentrations that did not affect the growth of nontransformed cells. In addition,
these extracts contain lowmolecularweight growth inhibitory compounds below 3 kD in size that combine
with larger compounds to more effectively inhibit melanoma cell growth. Future work should identify
these compounds, and evaluate their potential to prevent and treat melanoma and other cancers.
Copyright © 2016, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Skin cancer is the most common form of cancer and its inci-
dence is rising. Melanoma causes about 80% of all skin cancer
deaths, and is notoriously resistant to current treatments. Less than
25% of metastatic melanomas respond to existing therapies.1,2 In
addition, melanoma often reoccurs after initial response, and these
cases can be extremely aggressive. Patients with advanced mela-
noma have a median survival of less than 1 year, and a 3-year
survival rate of only 10e15%.3
Unfortunately, over 40 years of work and clinical trials with
alkylating agents (e.g. DTIC), taxanes (e.g. taxol), signaling in-
hibitors (e.g. tamoxifen), and cytokines (e.g. interluekins and
interferons) has not signiﬁcantly increased melanoma survival
rates.3,4 In fact, melanoma kills over 50,000 people around the
world each year.5 Alternative methods are clearly needed to pre-
vent and treat melanoma.
Hibiscus rosa-sinensis is a ﬂowering plant native to tropical Asia.6
Hibiscus is commonly consumed in teas made from its ﬂowers,
leaves, and roots. In addition to casual consumption, Hibiscus is also
used as an herbal medicine to treat hypertension, cholesterol pro-
duction, and cancer progression.7
Reports indicate that hibiscus extracts can inhibit the growth of
cancer cell types including mammary carcinoma,8 leukemia,9 and
melanoma.10 For example, recent studies found that Hibiscus
polyphenols inhibit melanoma cell growth and viability.10 How-
ever, while H. rosa-sinensis ﬂowers are commonly used to make
medicinal tea,11,12 these previous studies were performed with
organic solvent extracts of leaves from different strains, namely
Hibiscus sabdariffa.10
Here, we examined the effects of aqueous H. rosa-sinensis ﬂower
extract on melanoma cell growth. Results from these studies indi-
cate that this extract contains components that inhibit melanoma
* Corresponding author. Molecular Biology, School of Osteopathic Medicine,
Rowan University, B307 Science Center, 2 Medical Center Dr., Stratford, NJ 08084,
USA. Tel.: þ1 856 566 6718.
E-mail address: gary.goldberg@rowan.edu (G.S. Goldberg).
Peer review under responsibility of The Center for Food and Biomolecules,
National Taiwan University.
Contents lists available at ScienceDirect
Journal of Traditional and Complementary Medicine
journal homepage: http: / /www.elsevier .com/locate/ j tcme
http://dx.doi.org/10.1016/j.jtcme.2016.01.005
2225-4110/Copyright © 2016, Center for Food and Biomolecules, National Taiwan University. Production and hosting by Elsevier Taiwan LLC. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Journal of Traditional and Complementary Medicine 7 (2017) 45e49
cell growth. However, these data also suggest that more than one
component is responsible for this effect, and these components act
together to produce an optimal response. Thus, H. rosa-sinensis
ﬂowers may offer a source of products that can be used to prevent
or treat melanoma, possibly in combination with other therapies.
2. Materials and methods
2.1. Hibiscus extract preparation
Dried H. rosa-sinensis ﬂowers were incubated with 10 volumes
(w/v) of boiling water for 20 min and cooled to room temperature.
This 10% solution was then clariﬁed by centrifugation, sterilized by
ﬁltration through 0.2 micron ﬁlters (Millipore), frozen, and
lyophilized to dryness. This dried extract was suspended inwater to
a ﬁnal concentration of 50 mg/ml.
2.2. Extract fractionation
To examine molecular weights of bioactive compounds, extract
was fractionated as previously described.13 Brieﬂy, components
greater than 50 kD were concentrated over centrifugal membranes
with a 50 kD nominal molecular weight pore size (EMD Millipore
Amicon UFC5050). Filtrates were then concentrated over centrifu-
gal membranes with a 3 kD nominal molecular weight pore size
(EMD Millipore Amicon UFC5003) to concentrate components be-
tween 3 and 50 kD, and obtain material below 3 kD as ﬁltrates. Size
fractionation was veriﬁed by SDS-PAGE on 18% gels stained with
SilverQuest dye (Invitrogen LC6070). Concentrated material,
Fig. 1. Hibiscus extract inhibits melanoma cell growth. (a) B16F10 melanoma cells and nontransformed NIH3T3 ﬁbroblasts (5,000 cells per well) were grown overnight before being
incubated for 72 h with indicated concentrations of hibiscus extract and photographed (bar ¼ 280 microns). (b) Cells were counted and shown as the number of cells in a 500  500
micron area in the center of each well (mean þ SEM, n ¼ 3). Single and double asterisks denote p < 0.05 and p < 0.01 compared to untreated control cells, respectively.
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ﬁltrate, and unfractionated extract were diluted in cell culture
medium to achieve ﬁnal concentrations equivalent to 4 mg/ml of
original unfractionated extract.
2.3. Cell culture
B16, NIH3T3, and LA25 cells were maintained in DMEM
(Hyclone SH30021) supplemented with 25 mM HEPES (Hyclone
SH3027) and 10% FBS (Seradigm 1400-500) at 37 C in 5% CO2 and
100% humidity as described.14e18 B16 and NIH3T3 cells were plated
at 5000 cells/well in standard 24 well culture plates and allowed to
adhere to plates for 24 h. Different concentrations of aqueous plant
extract were then added and cells were incubated for an additional
72 h. LA25 cells were grown overnight at non permissive temper-
ature (40 C) before being incubated for 24 h at permissive (33 C)
and nonpermissive (40 C) temperatures with or without hibiscus
extract, and then stained with Trypan blue to distinguish living and
dead cells. Cells were analyzed on an inverted Zeiss Axiovert mi-
croscope and counted from images with the aid of Zeiss Axiovision
software as previously described.14,15 Cells treated with fraction-
ated extracts were trypsinized and counted with a Coulter counter
as previously described.13,15 Statistics were analyzed with Graph-
pad Prism Software version 5 as previously described.14,15
2.4. Western blotting
Protein extracted from LA25 cells grown at permissive (33 C)
and nonpermissive (40 C) temperature was analyzed by Western
blotting to detect total v-Src (Millipore 05-185), active Src (phos-
phorylated at tyrosine 416) (Millipore 04-857), and ß-actin (Sigma
A1978) as previously described.16e18
3. Results
3.1. H. rosa-sinensis ﬂower extract inhibits melanoma cell growth
An aqueous extract of H. rosa-sinensis ﬂowers was prepared
according to basic recipes used to make tea. Effects of this extract
on cell growth were examined after sterilization by ﬁltration. As
shown in Fig. 1, this extract inhibited melanoma cell growth in a
dose dependent manner. This extract reduced melanoma cell
growth by 2 fold at 1 mg/ml, and 4 fold at 2 mg/ml.
Interestingly, this extract preferentially inhibited growth of
melanoma cells over nontransformed ﬁbroblasts. Although there
did seem to be a trend for ﬁbroblast growth inhibition, this effect
was not signiﬁcant, even at concentrations up to 8 mg/ml (see
Fig. 1). These data are consistent with recent studies indicating that
H. sabdariffa leaf extracts contain polyphenols that speciﬁcally
inhibit the growth of melanoma cells, but not nontransformed
cells.10
3.2. Bioactive components of H. rosa-sinensis ﬂower extract can be
fractionated by size
The aqueous H. rosa-sinensis ﬂower extract was fractionated to
examine the nature of its bioactive components. Centrifugal
ﬁltration was used to obtain products greater than 50 kD, between
3 kD and 50 kD, and less than 3 kD. The effect of these fractions on
melanoma cell growth was then examined at an original concen-
tration of 4 mg/ml, which potently inhibited melanoma cell growth
(Fig. 1).
3.3. Bioactive components of H. rosa-sinensis ﬂower extract work
together to inhibit melanoma cell growth
The combined fractions of this extract inhibited melanoma cell
growth by over 60% as shown in Fig. 2. In addition, low molecular
weight components below 3 kD also inhibited cell growth, but to a
signiﬁcantly smaller extent of about 30%. Moreover, compounds
larger than 3 kD did not inhibit melanoma cell growth. Taken
together, these data suggest that while low molecular weight
compounds in H. rosa-sinensis ﬂower extract can inhibit melanoma
cell growth to some extent, they combine with other higher mo-
lecular weight compounds to double their effectiveness.
Fig. 2. Hibiscus extract contains multiple bioactive components. (a)B16F10 melanoma cells (5,000 cells per well) were grown overnight before being incubated for 72 h with no
extract (Control), unfractionated hibiscus extract (Total), or fractions containing components of hibiscus extract greater than 50 kD (>50 kD), between 3 and 50 kD (3e50 kD), or less
than 3 kD (<3 kD) and photographed (bar ¼ 350 microns). (b) Cells were counted and shown as percent of controls (mean þ SEM, n ¼ 3). Single and double asterisks denote p < 0.05
compared to control cells treated without extract and p < 0.1 between cells treated with total extract or fractions with components less than 3 kD as indicated.
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3.4. Hibiscus extract inhibits Src transformed cell growth, but not
oncogenic Src kinase activity
The Src kinase has been implicated in melanoma pro-
gression,19e21 and is being pursued as a potential chemotherapeutic
target.22,23 We utilized LA25 cells transformed by a temperature
sensitive oncogenic Src kinase construct to investigate the effects of
hibiscus extract on Src transformed cells and kinase activity. As
shown in Fig. 3a, hibiscus extract was preferentially toxic to these
cells transformed by Src kinase when grown at permissive tem-
perature. However, as shown in Fig. 3b, hibiscus treatment did not
inhibit Src kinase activity in these cells. These data suggest that
hibiscus extract contains compounds that affect elements down-
stream of the Src kinase, or unrelated pathways that control tumor
cell viability.
4. Discussion
Hibiscus has been consumed for many centuries. In particular,
ﬂowers from H. rosa-sinensis are used to prepare tea. This beverage
is purported to have medicinal properties that ameliorate condi-
tions including cardiac hypertension and cancer.7
Results from this study indicate that H. rosa-sinensis tea extracts
contain compounds that inhibit melanoma cell growth at concen-
trations that do not affect nontransformed cells. These data are
consistent with recent studies indicating that polyphenols from H.
sabdariffa inhibit melanoma cell growth.10 Although the poly-
phenols examined in previous studies were extracted with organic
solvents, they may also be present in aqueous extracts used in
traditional beverages.
Our results indicate that aqueous H. rosa-sinensis ﬂower extract
may also contain low molecular weight compounds that inhibit
melanoma cell growth. These may also be polyphenols such as
those obtained from leaves of different strains as previously re-
ported.10 However, our results also indicate that these compounds
actually work with other higher molecular weight compounds to
more effectively inhibit melanoma cell growth in a manner that
does not inhibit Src kinase activity. Future work should identify
these components and evaluate their potential to prevent and treat
melanoma, and possibly other cancers. It should be particularly
important to determine if these compounds can potentiate the
effects of other treatments including traditional cytotoxic thera-
pies, and more targeted agents including BRAF and CTLA4 blockers
which target oncogenic serine kinase signaling events and immu-
nomodulation, respectively.3,4
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